Filing Details
- Accession Number:
- 0001209191-21-009470
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 20:29:26
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 20:29:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Nutrition Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311282 | David Pezzullo | 800 W. Olympic Blvd Suite 406 Los Angeles CA 90015 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-08 | 20,764 | $26.65 | 168,737 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 13,743 | $55.83 | 154,994 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 6,816 | $33.85 | 161,810 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 5,061 | $55.83 | 156,749 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 29,508 | $39.79 | 186,257 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 24,579 | $55.83 | 161,678 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 43,668 | $31.26 | 205,346 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 33,978 | $55.83 | 171,368 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 45,902 | $28.60 | 217,270 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 34,614 | $55.83 | 182,656 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 35,642 | $0.00 | 218,298 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-02-08 | 17,672 | $55.83 | 200,626 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-10 | 5,644 | $56.73 | 194,982 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-10 | 15,801 | $57.61 | 179,181 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-10 | 13,238 | $58.35 | 165,943 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2021-02-08 | 20,764 | $0.00 | 20,764 | $26.65 |
| Common Stock | Stock Appreciation Rights | Disposition | 2021-02-08 | 6,816 | $0.00 | 6,816 | $33.85 |
| Common Stock | Stock Appreciation Rights | Disposition | 2021-02-08 | 29,508 | $0.00 | 29,508 | $39.79 |
| Common Stock | Stock Appreciation Rights | Disposition | 2021-02-08 | 43,668 | $0.00 | 43,668 | $31.26 |
| Common Stock | Stock Appreciation Rights | Disposition | 2021-02-08 | 45,902 | $0.00 | 45,902 | $28.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-05-18 | 2021-05-18 | No | 4 | M | Direct |
| 0 | 2015-03-01 | 2022-03-01 | No | 4 | M | Direct |
| 0 | 2016-06-21 | 2023-12-19 | No | 4 | M | Direct |
| 0 | 2019-05-09 | 2026-05-09 | No | 4 | M | Direct |
| 0 | 2020-02-27 | 2027-02-27 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period.
- Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs.
- This transaction was executed in multiple trades at prices ranging from $56.2100 to $56.9900. The price reported reflects the weighted average sale price of $56.7262. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $57.0900 to $57.9900. The price reported reflects the weighted average sale price of $57.6139. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $58.0000 to $58.6250. The price reported reflects the weighted average sale price of $58.3540. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering10,382 shares at an exercise price of $53.29 per share.
- The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014.
- Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 3,408 shares at an exercise price of $67.70 per share.
- The SARS were granted on March 1, 2012. 20% vested on March 1, 2013, 20% vested on March 1, 2014 and the remaining 60% vested on March 1, 2015.
- Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 14,754 shares at an exercise price of $79.58 per share.
- The SARS were granted on December 19, 2013. 20% vested on June 21, 2014, 20% vested on June 21, 2015 and the remaining 60% vested on June 21, 2016.
- Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 21,834 shares at an exercise price of $62.51 per share.
- The SARS were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019.
- Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 22,951 shares at an exercise price of $57.19 per share.
- The SARS were granted on February 27, 2017. 20% vested on February 27, 2018, 20% vested on February 27, 2019 and the remaining 60% vested on February 27, 2020.
Billionaire Hedge Funds
